The cGAS-STING pathway drives type I IFN immunopathology in COVID-19. Di Domizio J, Gulen MF, Saidoune F, Thacker VV, et al. Nature 2022 Jan 19. pii: 10.1038/s41586-022-04421.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Di Domizio J, Gulen MF, Saidoune F, Thacker VV, et al. The cGAS-STING pathway drives type I IFN immunopathology in COVID-19. Nature 2022 Jan 19. pii: 10.1038/s41586-022-04421.
PMID: 35045565